Skip to content
News

PhRMA's Medicare price negotiation suit rebuffed in latest blow to industry IRA challenge

August 27, 2026

August 27, 2026

In the latest in a string of setbacks in biopharma’s efforts to fight Medicare drug price negotiations, a lawsuit from the industry’s top lobbying group has been rejected at the appeals level.

This article was originally published on Fierce Healthcare.